Mike Rea examines why strategic marketing is of pivotal consequence to the success or failure of a pharmaceutical brand, putting the case for earlier implementation of rigorous, externally triangulated assessment of strategic marketing plans.
Joan Barnard, Rene Lai and Andrew Robson have delivered a line-by-line summary of all revisions, both major and minor, to the latest EFPIA codes, and offer insight into the likely implications for the pharmaceutical industry and its customers.
Liz Wager explains the concerns about the role of medical writers in developing peer-reviewed publications and helps writers and communications companies keep abreast of recent guidelines and new journal policies.
Dr Faiz Kermani draws on extensive references to explain the background to patient compliance issues and to set the scene for an exploration of how technology can be harnessed to improve this significant but widely under-acknowledged challenge.
This review by Eugene Pozniak provides a robust definition of CME and its purpose, details the wide-ranging activities considered worthy of accreditation and looks at industry involvement in CME activities, exploring the many pitfalls and benefits.
